Estensen R D, White J G
Am J Pathol. 1974 Mar;74(3):441-52.
Phorbol myristate acetate (PMA) the active ingredient of croton oil, is a potent stimulus of irreversible platelet aggregation. The present study has examined the effects of PMA on platelet fine structure during aggregation and after incubation. PMA appears to act primarily on channels of the open canalicular system and intracellular granules. Small amounts of the agent cause dilatation of some open channels and conversion of granules to swollen vacuoles. Platelet discoid shape is not affected significantly by the changes in channels and vacuoles, and aggregation occurs without shape change. EDTA inhibits PMA-induced aggregation but does not prevent the conversion of platelet granules to vacuoles. In unstirred systems PMA causes similar changes in platelet fine structure and spontaneous aggregation. The drug appears to affect the permeability barrier separating granule contents from open channels, thereby leading to osmotic swelling of the storage organelles. PMA is the first agent observed to have a selective influence on the stability of platelet granules.
佛波醇肉豆蔻酸酯乙酸酯(PMA)是巴豆油的活性成分,是不可逆血小板聚集的强效刺激物。本研究检测了PMA在血小板聚集过程中和孵育后对血小板精细结构的影响。PMA似乎主要作用于开放小管系统的通道和细胞内颗粒。少量该试剂会导致一些开放通道扩张以及颗粒转变为肿胀的液泡。血小板盘状形态并未因通道和液泡的变化而受到显著影响,并且聚集发生时形态不变。乙二胺四乙酸(EDTA)抑制PMA诱导的聚集,但不能阻止血小板颗粒转变为液泡。在未搅拌的系统中,PMA会导致血小板精细结构发生类似变化以及自发聚集。该药物似乎影响了将颗粒内容物与开放通道分隔开的渗透屏障,从而导致储存细胞器的渗透性肿胀。PMA是观察到的第一种对血小板颗粒稳定性有选择性影响的试剂。